Germany · Delayed Price · Currency is EUR aXichem AB Statistics
Total Valuation
aXichem AB has a market cap or net worth of EUR 12.82 million. The enterprise value is 12.75 million.
| Market Cap | 12.82M |
| Enterprise Value | 12.75M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 59.11M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +85.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.63% |
| Owned by Institutions (%) | 18.90% |
| Float | 39.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.93 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 4.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.98 |
| EV / Sales | 8.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.17 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.22 |
Financial Efficiency
Return on equity (ROE) is -30.24% and return on invested capital (ROIC) is -17.27%.
| Return on Equity (ROE) | -30.24% |
| Return on Assets (ROA) | -16.03% |
| Return on Invested Capital (ROIC) | -17.27% |
| Return on Capital Employed (ROCE) | -29.56% |
| Revenue Per Employee | 205,130 |
| Profits Per Employee | -228,350 |
| Employee Count | 7 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 0.74 |
Taxes
In the past 12 months, aXichem AB has paid 2,894 in taxes.
| Income Tax | 2,894 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +97.92% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +97.92% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 0.18 |
| Relative Strength Index (RSI) | 41.57 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, aXichem AB had revenue of EUR 1.44 million and -1.60 million in losses. Loss per share was -0.03.
| Revenue | 1.44M |
| Gross Profit | 814,419 |
| Operating Income | -1.55M |
| Pretax Income | -1.60M |
| Net Income | -1.60M |
| EBITDA | -1.30M |
| EBIT | -1.55M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 278,679 in cash and 210,931 in debt, giving a net cash position of 67,748.
| Cash & Cash Equivalents | 278,679 |
| Total Debt | 210,931 |
| Net Cash | 67,748 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.25M |
| Book Value Per Share | 0.09 |
| Working Capital | 1.02M |
Cash Flow
| Operating Cash Flow | -1.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 56.72%, with operating and profit margins of -108.14% and -111.32%.
| Gross Margin | 56.72% |
| Operating Margin | -108.14% |
| Pretax Margin | -111.13% |
| Profit Margin | -111.32% |
| EBITDA Margin | -90.39% |
| EBIT Margin | -108.14% |
| FCF Margin | n/a |
Dividends & Yields
aXichem AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -85.07% |
| Shareholder Yield | -85.07% |
| Earnings Yield | -12.47% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |